DCTH
DELCATH SYSTEMS, INC.
NASDAQ · Healthcare · Medical - Devices · US
$14.37
+2.06%Year over year
Reported trailing growth
- Revenue
- +35.8%
- EBITDA
- -87.1%
- EBIT
- —
- EPS
- -83.0%
- Free cash flow
- +352.7%
- Operating cash flow
- +303.9%
Forward estimates
Based on analyst estimates
- Revenue
- +34.2%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +215.3%
- EBITDA
- +114.8%
- EBIT
- +105.3%
- Net income
- +110.2%
- EPS
- +175.5%
- Free cash flow
- +209.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026